Penumbra has announced that it has received CE mark approval and so has initiated the European launch of BMX81 and BMX96, devices which are designed for neurovascular management of ischaemic and haemorrhagic stroke.
This announcement further expands the company’s neuro portfolio in Europe, following the news in early May when Penumbra launched three new RED reperfusion catheters (RED 43, RED 72 with SENDit technology, and RED 78).
“Physicians in Europe now have more options to serve their patients using our expanded portfolio. With five innovative devices introduced in Europe in a matter of months, our dedication to improving stroke care enables us to provide physicians with customised stroke solutions,” said Joan Kristensen, head of the Europe, Middle East and Africa region for Penumbra.
Unlike traditional access catheters, Penumbra’s BMX81 and BMX96 are made using laser-cut stainless steel hypotube technology, offering stability and trackability. They are designed to allow physicians to navigate the brain’s complex anatomy and can be used from either a femoral or radial access approach (i.e. via groin or wrist). The stainless steel hypotube also allows for a larger inner diameter while maintaining a lower outer diameter without compromising support. This expands intraprocedural options in both ischaemic and haemorrhagic stroke.
“I need to be able to trust that my access catheters can provide the stability that I need. The new BMX catheters promise excellent support. With their expanded inner diameters, I will be able to increase therapeutic options for my patients, especially when going radial,” said Markus Holtmannspötter, (Klinikum Nürnberg, Nürnberg, Germany).
With 20 years of experience optimising science-based aspiration thrombectomy (S-BAT), Penumbra’s catheters are engineered with the latest technology in trackability and aspiration to address a wide range of large vessel occlusions and to navigate the challenging vasculature of the brain.
